◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › SLBT

SL Science Holding Limited (SLBT) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

SL Science Holding Limited (SLBT) operates in the Biotechnology industry and is headquartered in Taipei, Taiwan. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, SLBT reported $2M in revenue and ($4M) in net income.

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series.

Interactive charts & full statements → Open the SLBT valuation workbench →

SLBT Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-31
Total Revenue$2M$3M$1M
Gross Profit$1M$2M$1M
Operating Income (EBIT)($4M)($1M)$0M
Net Income($4M)($1M)$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SLBT Free Cash Flow History

SLBT Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-31
Total Assets$3M$6M$4M
Total Liabilities$0M$0M$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SLBT viewer.

Other Companies in Biotechnology

← SLBAll stocksSLDB →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.